top of page

About the C3

The Canadian Cholangiocarcinoma Collaborative (C3) is a partnership among patients, caregivers, oncologists and researchers which was formed to grow hope in patients and families affected by cholangiocarcinoma.

Our mission is to translate that hope into better outcomes by enhancing patient access to personalized testing, expert opinions and treatments, including targeted agents and immunotherapy through clinical trials, and to create a high-quality immunotherapy pipeline for novel therapeutic discoveries.


We believe that Research is Care.

C3 emblem

Increase HOPE in patients

Hope means never giving up. We want to give hope and support to anyone affected by cholangiocarcinoma. This is why we have a dedicated C3 "Research Navigator" whose role is to help patients navigate through their journey with cancer. This includes assisting patients participate in C3 initiatives and opportunities such as:

  • The International Cholangiocarcinoma Patient Registry

  • National BTC Multidisciplinary Oncology Rounds

  • Clinical Trial info sessions and Trial Matching

  • The C3 "Hope Study"

Team Leads

OUR COLLABORATIVE NETWORK

The Ottawa Hospital Logo
OHRI Ottawa hospital research institute logo
CHUM logo
UHN logo
mcgill logo
bccancer research
Michael smith genome sciences centre logo
oicr genomics
cholangiocarcinoma foundation logo

FUNDED BY

Canadian Cancer Society
CIHR logo
bottom of page